Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Diabetes Mellitus Type 2 in Obese clinical trials
A small indexed set (2 trials) with no open enrollment listed right now.
Corpus placement: #7,188 of 28,707 conditions by registered trial count.
2 US clinical trials · none currently recruiting · #7,188 of 28,707 conditions by registered trial count
Diabetes Mellitus Type 2 in Obese: 2 US clinical trials tracked, none currently recruiting.
Diabetes Mellitus Type 2 in Obese is the subject of 2 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. The most active sponsor is Physicians Committee for Responsible Medicine, running 1 of these trials.
Enrollment posture brief
Registry condition diabetes-mellitus-type-2-in-obese
OPEN 0 | RECR 0% | LATE 0 | EARLY 0 | RANK #7188 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)
Diabetes Mellitus Type 2 in Obese has no open enrollment in this registry pull (2 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Diabetes Mellitus Type 2 in Obese on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Diabetes Mellitus Type 2 in Obese is recruiting below its size-band peers.
0 of 2 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Indexed trials (enrollment closed)
2 total, page 1 of 1
TODAY2 Phase 1 Immediate Post-Intervention Observational Follow-up Study
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NCT01364350
The Effect of a Low-fat Vegan Dietary Intervention on Intracellular Lipid, Insulin Sensitivity, and Glycemic Control in Type 2 Diabetes
Physicians Committee for Responsible Medicine
NCT06106035
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Diabetes Mellitus Type 2 in Obese records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Diabetes Mellitus Type 2 in Obese trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Diabetes Mellitus Type 2 in Obese page
2 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- No Diabetes Mellitus Type 2 in Obese trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Physicians Committee for Responsible Medicine sponsors the most Diabetes Mellitus Type 2 in Obese trials on record, review their full trial history before evaluating a specific study. See Physicians Committee for Responsible Medicine's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Diabetes Mellitus Type 2 in Obese condition card totals 2 registered trials; most-linked intervention standard of care in general clinical practice; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.